---
title: "ACT Speeds Development of Medications for Pediatric Autoimmune Diseases"
image: "https:\/\/i.ytimg.com\/vi\/8oqR6v8mf-8\/hqdefault.jpg"
vid_id: "8oqR6v8mf-8"
categories: "Nonprofits-Activism"
tags: ["Seattle Children's Research Institute","lupus","pediatric lupus"]
date: "2021-10-24T02:50:38+03:00"
vid_date: "2014-06-11T01:21:29Z"
duration: "PT5M53S"
viewcount: "653"
likeCount: "2"
dislikeCount: "0"
channel: "Seattle Children's"
---
{% raw %}The Alliance for Children's Therapeutics (ACT) was formed to develop better medications for children and teens with autoimmune diseases like lupus, multiple sclerosis and juvenile arthritis - faster than ever before.<br /><br />ACT unites one of the nation's top-five pediatric research institutions - Seattle Children's Research Institute  - with Kineta, Inc., a leading biotechnology firm.<br /><br />To learn more, visit: <br /><br />ACT: <a rel="nofollow" target="blank" href="http://childrenstherapeutics.org/">http://childrenstherapeutics.org/</a><br />Seattle Children's Research Institute: <a rel="nofollow" target="blank" href="http://www.seattlechildrens.org/research/">http://www.seattlechildrens.org/research/</a><br />Kineta, Inc.: <a rel="nofollow" target="blank" href="http://www.kinetabio.com/">http://www.kinetabio.com/</a>{% endraw %}
